Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.
暂无分享,去创建一个
N. Robert | D. Tripathy | S. Shak | C. Vogel | M. Cobleigh | L. Fehrenbacher | D. Slamon | S. Scholl | J. Wolter | V. Paton | G. Lieberman | S. Scholl